Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

A pilot-test to support healthcare providers in promoting vaccine uptake among individuals with intellectual and developmental disabilities

Hotez E, Rava J, Khorasani L, Levenson AP, Shen T, Chen L, Klomhaus AM, Kuo AA. A pilot-test to support healthcare providers in promoting vaccine[...]

The Association between the Social Vulnerability Index and Access to California High School Athletic Trainers

Tao F, Turner C, Kliethermes S, Luke A, Berrigan W, Hatamiya N. The Association between the Social Vulnerability Index and Access to California High School[...]

Automated quantification of anterior chamber cells using swept-source anterior segment optical coherence tomography

Pillar S, Kadomoto S, Chen K, Gonzalez SS, Cherian N, Privratsky JK, Zargari N, Jackson NJ, Corradetti G, Chen JL, Sadda SR, Holland GN, Tsui[...]